The Good Clinic Expands Services with Pharmacogenetic Testing by Xact Laboratories
Minneapolis, MN, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- The Good Clinic™ is deepening its service offerings to include pharmacogenomic testing through Xact Laboratories, an Ohio-based biotechnology company focused on providing state-of-the-art molecular diagnostic tests. The product, XactMed4U™, can help clinicians understand how certain medications may work best for individual patients based on their unique genetics, resulting in better patient outcomes and potentially reduced costs. In alignment with the mission of providing accessible and customized health care, all The Good Clinic locations will offer the service.
- In alignment with the mission of providing accessible and customized health care, all The Good Clinic locations will offer the service.
- Through the pharmacogenetics testing services with Xact Laboratories , The Good Clinic will have the ability to provide more accurate diagnostics and treatments for clients with behavioral health conditions.
- Pharmacogenomics is a leading-edge technology in the healthcare industry, said The Good Clinic Chief Nurse Practitioner Officer Kevin Lee Smith.
- Mitesco operations and subsidiaries include The Good Clinic, LLC ("The Good Clinic").